Key Market Indicators
Czech antacid medicine sales are predicted to reach around $4.7 million by 2026. In 2021, the market totaled $4.7 million, a slight 0.2% annual growth on average since 1995. At the start of 2021, the Czech Republic ranked tenth in the industry. Greece, however, overtook the Czech Republic with a market size of $4.7 million. Italy, Germany and Chile ranked second, third and fourth respectively.
